These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 324036)

  • 1. Controlled trial of aspirin in cerebral ischemia.
    Fields WS; Lemak NA; Frankowski RF; Hardy RJ
    Stroke; 1977; 8(3):301-14. PubMed ID: 324036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of aspirin in cerebral ischemia.
    Fields WS; Lemak NA; Frankowski RF; Hardy RJ; Bigelow RH
    Circulation; 1980 Dec; 62(6 Pt 2):V90-6. PubMed ID: 7002356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of aspirin in cerebral ischemia. Part II: surgical group.
    Fields WS; Lemak NA; Frankowski RF; Hardy RJ
    Stroke; 1978; 9(4):309-19. PubMed ID: 354098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persantine Aspirin Trial in cerebral ischemia. The American-Canadian Co-operative Study Group.
    Stroke; 1983; 14(1):99-103. PubMed ID: 6337428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group.
    Stroke; 1985; 16(3):406-15. PubMed ID: 2860740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group.
    Uk-Tia Study Group
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):316-20. PubMed ID: 2894232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study.
    Biller J; Bruno A; Adams HP; Godersky JC; Loftus CM; Mitchell VL; Banwart KJ; Jones MP
    Stroke; 1989 Apr; 20(4):441-7. PubMed ID: 2648650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. The Dutch TIA Study Group.
    Stroke; 1988 Apr; 19(4):512-7. PubMed ID: 2896402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of aspirin and sulfinpyrazone in patients with TIA.
    Candelise L; Landi G; Perrone P; Bracchi M; Brambilla G
    Stroke; 1982; 13(2):175-9. PubMed ID: 7039004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of aspirin in cerebral ischemia: an addendum.
    Lemak NA; Fields WS; Gary HE
    Neurology; 1986 May; 36(5):705-10. PubMed ID: 3517694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation.
    Gårde A; Samuelsson K; Fahlgren H; Hedberg E; Hjerne LG; Ostman J
    Stroke; 1983; 14(5):677-81. PubMed ID: 6658949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
    J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
    Bousser MG; Eschwege E; Haguenau M; Lefaucconnier JM; Thibult N; Touboul D; Touboul PJ
    Stroke; 1983; 14(1):5-14. PubMed ID: 6401878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.
    Sorensen PS; Pedersen H; Marquardsen J; Petersson H; Heltberg A; Simonsen N; Munck O; Andersen LA
    Stroke; 1983; 14(1):15-22. PubMed ID: 6337425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for transient ischemic attacks.
    Med Lett Drugs Ther; 1980 Aug; 22(17):71-2. PubMed ID: 6995822
    [No Abstract]   [Full Text] [Related]  

  • 17. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group.
    Lancet; 1991 Nov; 338(8779):1345-9. PubMed ID: 1682734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose aspirin on functional outcome from cerebral vascular events in women.
    Rist PM; Buring JE; Kase CS; Kurth T
    Stroke; 2013 Feb; 44(2):432-6. PubMed ID: 23306328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.
    Canadian Cooperative Study Group
    N Engl J Med; 1978 Jul; 299(2):53-9. PubMed ID: 351394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.